-
Reliance Industr
1,411.85 1,608.95(%) -
Mazagon Dock
3,149.70 3,149.70(%) -
Bajaj Finance
8,560.00 6,376.55(%) -
Garden Reach Sh.
1,855.00 890.05(%) -
Cochin Shipyard
1,575.50 1,169.00(%) -
Tata Motors
641.10 542.55(%) -
Hind.Aeronautics
4,466.00 3,045.95(%) -
Paras Defence
1,469.00 1,592.75(%) -
Torrent Pharma.
3,300.00 2,513.05(%) -
Sonata Software
446.50 762.00(%) -
Data Pattern
2,450.00 1,350.50(%) -
IndusInd Bank
843.10 1,550.00(%) -
Samvardh. Mothe.
131.75 107.30(%) -
Bharat Electron
312.50 221.00(%) -
Trent
5,130.00 4,197.50(%) -
Varun Beverages
507.45 419.40(%) -
ICICI Bank
1,415.10 1,051.50(%) -
Vedanta
423.20 527.00(%) -
Hitachi Energy
14,879.00 16,534.50(%) -
Tech Mahindra
1,510.60 1,807.40(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Brawn Biotech Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Indian Private
- BSE Code : 4887.0
- ISIN : INE899B01015
-
Today’s Low
17.24 -
Today’s High
18.14

-
Open
18.14 -
Perv Close
18.14 -
52W Low
15.46 -
52W High
27.82
Key Indicators
-
P/E(TTM)
0.00
-
Mar.Cap (₹Cr.)
5.17
-
Div & Yield %
0.00
-
Book Value(₹)
14.10
-
Debt-Equity Ratio
-4.96
-
AGM Date
30-Apr-2025
-
EPS
0.00
-
P/E Ratio
0.00
Financials Ratios
-
Debt-Equity Ratio
-
-
Mar.Cap (₹Cr.)
5.17
-
RONW (%)
-
-
ROCE (%)
-
Score Board
-
Equity (₹ in Cr.)
3.00
-
BV (₹)
14.10
-
Sales( ₹ in Cr.)
16.49
-
NP (in Cr.)
-1.24
-
NP Var(%)
-43.0
-
Div%
0.0
-
CPS (₹)
-3.80
-
EPS (₹)
-4.10
-
Traded Value (₹ in Lakhs)
5.17
-
52 Week High
27.82
-
52 Week Low
15.46
-
Price BSE
17.0
-
Price NSE
0.00
-
Market Capital( in Cr.)
5.17
-
P/C Ratio
-4.50
-
P/E Ratio
-4.10
-
Price Vs.BV
-4.10
-
12-Feb-2025( 05:52)
Results - Announcements - Brawn... - Net Loss of Brawn Biotech repo...
-
05-Feb-2025( 12:58)
Corporate News - Brawn... - Brawn Biotech will hold a meet...
-
14-Nov-2024( 05:48)
Results - Announcements - Brawn... - Net Loss of Brawn Biotech repo...
-
11-Nov-2024( 12:21)
Corporate News - Brawn... - Brawn Biotech will hold a meet...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar | 2019 Mar |
---|---|---|---|---|---|---|
INCOME : | ||||||
Sales Turnover | 16.49 | 22.23 | 8.62 | 34.98 | 49.62 | 65.18 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 16.49 | 22.23 | 8.62 | 34.98 | 49.62 | 65.18 |
Other Income | 0.09 | 0.01 | 0.00 | 0.31 | 0.17 | 0.74 |
Stock Adjustments | 1.23 | 0.07 | 4.47 | -0.13 | 0.05 | -0.01 |
Total Income | 17.81 | 22.31 | 13.09 | 35.16 | 49.84 | 65.91 |
EXPENDITURE : | ||||||
Raw Materials | 15.59 | 19.24 | 11.05 | 29.89 | 42.15 | 58.49 |
Power and Fuel Cost | 0.08 | 0.06 | 0.02 | 0.04 | 0.05 | 0.05 |
Employee Cost | 1.40 | 1.40 | 1.80 | 2.36 | 3.08 | 3.02 |
Other Manufacturing Expenses | 0.35 | 0.34 | 0.40 | 1.64 | 1.56 | 0.13 |
Selling and Administration Expenses | 1.76 | 1.55 | 1.81 | 1.50 | 2.07 | 2.29 |
Miscellaneous Expenses | 0.01 | 0.00 | 0.01 | 0.01 | 0.02 | 0.01 |
Employee Benefit Expenses | 1.40 | 1.40 | 1.80 | 2.36 | 3.08 | 3.02 |
Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Expenses | 19.20 | 22.60 | 15.09 | 35.44 | 48.93 | 64.00 |
Operating Profit | -1.38 | -0.29 | -2.00 | -0.29 | 0.90 | 1.91 |
Interest | 0.06 | 0.01 | 0.06 | 0.04 | 0.05 | 0.07 |
Gross Profit | -1.44 | -0.30 | -2.06 | -0.33 | 0.85 | 1.84 |
Depreciation | 0.10 | 0.11 | 0.05 | 0.03 | 0.03 | 0.03 |
Profit Before Tax | -1.54 | -0.41 | -2.11 | -0.36 | 0.82 | 1.81 |
Current Tax | 0.00 | -0.01 | 0.00 | 0.28 | 0.23 | 0.46 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | -0.30 | 0.46 | -0.47 | -0.08 | 0.00 | 0.02 |
Reported Net Profit | -1.25 | -0.87 | -1.64 | -0.55 | 0.59 | 1.33 |
Extraordinary Items | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adjusted Net Profit | -1.24 | -0.87 | -1.64 | -0.55 | 0.59 | 1.33 |
Adjustment below Net Profit | 0.00 | -0.04 | 0.07 | 0.08 | 0.01 | -0.31 |
P & L Balance brought forward | 1.19 | 2.10 | 3.68 | 4.14 | 3.54 | 2.51 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P & L Balance carried down | -0.05 | 1.19 | 2.10 | 3.68 | 4.14 | 3.54 |
Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Per Share-Unit Curr | -4.16 | -2.89 | -5.48 | -1.84 | 1.97 | 4.44 |
Earnings Per Share(Adj)-Unit Curr | -4.16 | -2.89 | -5.48 | -1.84 | 1.97 | 4.44 |
Book Value | 16.88 | 21.03 | 24.07 | 29.31 | 30.87 | 28.85 |
Book Value(Adj)-Unit Curr | 16.88 | 21.03 | 24.07 | 29.31 | 30.87 | 28.85 |